event
Broken Dawn Antiviral Race
The source-specific Broken Dawn pursuit of a possible broad-spectrum antiviral, with April Kelleher and Division Agents racing a Mantis-directed operation to reach the Ann Arbor research lead.
A possible antiviral, not a finished cure
Broken Dawn's published premise centers on a potential broad-spectrum antiviral. The archive records that as a source-specific research lead and does not promote it into a confirmed cure for the wider franchise. [1][2][3]
The race for Ann Arbor
The licensed novel frames the Ann Arbor site as a contested research destination. April, Aurelio and their allies work to protect the lead while the Mantis-directed operation tries to control it; the resulting intelligence moves on to Washington. [3]
Claim ledger
Every factual statement below must retain at least one traceable source.
- confirmed
Ubisoft's published premise identifies a possible broad-spectrum antiviral as the research lead at the center of Broken Dawn's Midwest journey. [1][2]
- confirmed
In the novel's source-specific plot, the Ann Arbor research lead is threatened by the Mantis-directed operation while information and samples are moved toward Washington. [3]
- editorial distinction
Broken Dawn's potential antiviral is a novel-specific research lead; its existence is not presented here as proof of a completed, franchise-wide cure. [1][3]
Related records
Sources
- [1] The Division: Broken Dawn Novel Explores Effects of Global Collapse — Ubisoft News (2019-03-26). Accessed 2026-07-28.
- [2] Find Out More About The Division With The Books Of The Game — Ubisoft (2019-01-09). Accessed 2026-07-28.
- [3] Tom Clancy's The Division: Broken Dawn — Penguin Random House Library Marketing (2019-03-26). Accessed 2026-07-28.